These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1193 related articles for article (PubMed ID: 27176634)
21. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer. Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783 [TBL] [Abstract][Full Text] [Related]
22. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Jin Y; Cui Z; Li X; Jin X; Peng J Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533 [TBL] [Abstract][Full Text] [Related]
23. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma. Xiong J; Liu Y; Jiang L; Zeng Y; Tang W Jpn J Clin Oncol; 2016 Apr; 46(4):378-84. PubMed ID: 26848077 [TBL] [Abstract][Full Text] [Related]
24. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781 [TBL] [Abstract][Full Text] [Related]
27. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
29. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway. Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968 [TBL] [Abstract][Full Text] [Related]
30. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells. Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267 [TBL] [Abstract][Full Text] [Related]
31. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
32. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway. Guan Y; Zhang J; Cai X; Cai Y; Song Z; Huang Y; Qian W; Pan Z; Zhang X Gene; 2024 Mar; 897():148040. PubMed ID: 38065426 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion. Wang SH; Zhang MD; Wu XC; Weng MZ; Zhou D; Quan ZW Tumour Biol; 2016 Sep; 37(9):12867-12875. PubMed ID: 27449039 [TBL] [Abstract][Full Text] [Related]
35. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787 [TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition. Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer. Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791 [TBL] [Abstract][Full Text] [Related]
39. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K. Guo HM; Yang SH; Zhao SZ; Li L; Yan MT; Fan MC Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4090-4097. PubMed ID: 30024596 [TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis. Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]